Daiwa Securities Group
CBIO

Daiwa Securities Group’s Crescent Biopharma CBIO Stock Holding History

Daiwa Securities Group’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3
Closed -$1K – 1272
2020
Q3 		$1K Hold
3
– – ﹤0.01% 1164
2020
Q2 		$1K Hold
3
– – ﹤0.01% 1187
2020
Q1 		$1K Hold
3
– – ﹤0.01% 1190
2019
Q4 		$1K Hold
3
– – ﹤0.01% 1185
2019
Q3 		$1K Hold
3
– – ﹤0.01% 1151
2019
Q2 		$3K Hold
3
– – ﹤0.01% 1130
2019
Q1 		$3K Buy
3
+1
+50% +$1.15K ﹤0.01% 1106
2018
Q4 		$2K Hold
2
– – ﹤0.01% 1105
2018
Q3 		$3K Hold
2
– – ﹤0.01% 1105
2018
Q2 		$3K Hold
2
– – ﹤0.01% 1124
2018
Q1 		$3K Buy
+2
New +$4.16K ﹤0.01% 1103

Other funds holding CBIO

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $60.6B AUM 31.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return